Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bauer

Showing results (111-120 of 171) with videos related to

Pageof 18
Sort By:
Journal of Gastroenterology and Hepatology|May 8, 2019
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertensionGeorg Semmler, Benedikt Simbrunner, Bernhard Scheiner, et al.
Journal of Hepatology|October 19, 2020
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortalityDalila Costa, Benedikt Simbrunner, Mathias Jachs, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 17, 2020
Recent outbreaks of severe hepatitis A virus infections in ViennaDavid Bauer, Anna Farthofer, David Chromy, et al.
Nuclear Medicine and Biology|November 30, 2024
Pretargeted alpha therapy in MUC16-positive high-grade serous ovarian cancerKyeara N Mack, David Bauer, Lukas M Carter, et al.
Journal of Hepatology|January 13, 2024
Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradientMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
United European Gastroenterology Journal|May 29, 2021
Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failureLorenz Balcar, Georg Semmler, Katharina Pomej, et al.
Stroke|September 24, 2011
Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhageSherry H-Y Chou, Po-Shun Lee, Rachael G Konigsberg, et al.
Wiener Klinische Wochenschrift|June 28, 2021
Outcomes of an HCV elimination program targeting the Viennese MSM populationMathias Jachs, Teresa Binter, David Chromy, et al.
United European Gastroenterology Journal|March 25, 2023
Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care centerMathias Jachs, Raphael Sauberer, Alexander Stiegler, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2021
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and DeathMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
Pageof 18

Showing results (111-120 of 171) with videos related to

Sort By:
Pageof 18
Journal of Gastroenterology and Hepatology|May 8, 2019
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertensionGeorg Semmler, Benedikt Simbrunner, Bernhard Scheiner, et al.
Journal of Hepatology|October 19, 2020
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortalityDalila Costa, Benedikt Simbrunner, Mathias Jachs, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 17, 2020
Recent outbreaks of severe hepatitis A virus infections in ViennaDavid Bauer, Anna Farthofer, David Chromy, et al.
Nuclear Medicine and Biology|November 30, 2024
Pretargeted alpha therapy in MUC16-positive high-grade serous ovarian cancerKyeara N Mack, David Bauer, Lukas M Carter, et al.
Journal of Hepatology|January 13, 2024
Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradientMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
United European Gastroenterology Journal|May 29, 2021
Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failureLorenz Balcar, Georg Semmler, Katharina Pomej, et al.
Stroke|September 24, 2011
Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhageSherry H-Y Chou, Po-Shun Lee, Rachael G Konigsberg, et al.
Wiener Klinische Wochenschrift|June 28, 2021
Outcomes of an HCV elimination program targeting the Viennese MSM populationMathias Jachs, Teresa Binter, David Chromy, et al.
United European Gastroenterology Journal|March 25, 2023
Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care centerMathias Jachs, Raphael Sauberer, Alexander Stiegler, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2021
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and DeathMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
Pageof 18